Bone marrow stem cell as a potential treatment for diabetes

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Li, Ming ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUTAMATE DECARBOXYLASE; INTERLEUKIN 6; TRANSCRIPTION FACTOR PDX 1; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL POPULATION; ENDOTHELIAL PROGENITOR CELL; GLYCEMIC CONTROL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; THYMOCYTE;

EID: 84879369217     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/329596     Document Type: Review

References (61)

1. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2004 27 supplement 1 S5 S10
2. Hussain M. A., Theise N. D., Stem-cell therapy for diabetes mellitus. The Lancet 2004 364 9429 203 209 2-s2.0-3042758642 10.1016/S0140-6736(04)16635-X (Pubitemid 38891693)
3. Delovitch T. L., Singh B., The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997 7 727 738 (Pubitemid 28064887)
4. Atkinson M. A., Leiter E. H., The NOD mouse model of type 1 diabetes: as good as it gets? Nature Medicine 1999 5 6 601 604 2-s2.0-0033001488 10.1038/9442 (Pubitemid 29289413)
5. Marrack P., Parker D. C., A little of what you fancy. Nature 1994 368 6470 397 398 2-s2.0-0028783081 10.1038/368397a0 (Pubitemid 24115342)
6. + T cell-avidity maturation in autoimmune diabetes. Journal of Clinical Investigation 2005 115 7 1879 1887 2-s2.0-22144482328 10.1172/JCI24219 (Pubitemid 40979727)
7. Gardner J. M., Fletcher A. L., Anderson M. S., Turley S. J., AIRE in the thymus and beyond. Current Opinion in Immunology 2009 21 6 582 589 2-s2.0-70449492717 10.1016/j.coi.2009.08.007
8. Vafiadis P., Bennett S. T., Todd J. A., Nadeau J., Grabs R., Goodyer C. G., Wickramasinghe S., Colle E., Polychronakos C., Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nature Genetics 1997 15 3 289 292 2-s2.0-0031018819 10.1038/ng0397-289 (Pubitemid 27098725)
9. Serreze D. V., Chapman H. D., Varnum D. S., Hanson M. S., Reifsnyder P. C., Richard S. D., Fleming S. A., Leiter E. H., Shultz L. D., B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. Journal of Experimental Medicine 1996 184 5 2049 2053 2-s2.0-0029826977 (Pubitemid 26404497)
10. Akashi M., Nagafuchi S., Anzai K., Kondo S., Kitamura D., Wakana S., Ono J., Kikuchi M., Niho Y., Watanabe T., Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. International Immunology 1997 9 8 1159 1164 2-s2.0-8544271680 10.1093/intimm/9.8.1159 (Pubitemid 27361759)
11. Hu C. Y., Rodriguez-Pinto D., Du W., Ahuja A., Henegariu O., Wong F. S., Shlomchik M. J., Wen L., Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. Journal of Clinical Investigation 2007 117 12 3857 3867 2-s2.0-36849027817 10.1172/JCI32405 (Pubitemid 350224095)
12. Yang L. J., Liver stem cell-derived β -cell surrogates for treatment of type 1 diabetes. Autoimmunity Reviews 2006 5 6 409 413 2-s2.0-33746500855 10.1016/j.autrev.2005.10.009 (Pubitemid 44143034)
13. Xu X., D'Hoker J., Stangé G., Bonné S., De Leu N., Xiao X., VanDeCasteele M., Mellitzer G., Ling Z., Pipeleers D., Bouwens L., Scharfmann R., Gradwohl G., Heimberg H., β cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008 132 2 197 207 2-s2.0-38749108893 10.1016/j.cell.2007.12.015 (Pubitemid 351181232)
14. Alipio Z., Liao W., Roemer E. J., Waner M., Fink L. M., Ward D. C., Ma Y., Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic β -like cells. Proceedings of the National Academy of Sciences of the United States of America 2010 107 30 13426 13431 2-s2.0-77955814966 10.1073/pnas.1007884107
15. Segev H., Fishman B., Ziskind A., Shulman M., Itskovitz-Eldor J., Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells 2004 22 3 265 274 2-s2.0-2942615532 (Pubitemid 38736611)
16. Brolén G. K. C., Heins N., Edsbagge J., Semb H., Signals from the embryonic mouse pancreas induce differentiation of human embryonic stem cells into insulin-producing β -cell-like cells. Diabetes 2005 54 10 2867 2874 2-s2.0-25844454068 10.2337/diabetes.54.10.2867 (Pubitemid 41401081)
17. Pittenger M. F., Mackay A. M., Beck S. C., Jaiswal R. K., Douglas R., Mosca J. D., Moorman M. A., Simonetti D. W., Craig S., Marshak D. R., Multilineage potential of adult human mesenchymal stem cells. Science 1999 284 5411 143 147 2-s2.0-0033515827 10.1126/science.284.5411.143 (Pubitemid 29282067)
18. Colter D. C., Class R., DiGirolamo C. M., Prockop D. J., Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proceedings of the National Academy of Sciences of the United States of America 2000 97 7 3213 3218 2-s2.0-0034724369 10.1073/pnas.070034097 (Pubitemid 30183281)
19. Khoo C. P., Pozzilli P., Alison M. R., Endothelial progenitor cells and their potential therapeutic applications. Regenerative Medicine 2008 3 6 863 876 2-s2.0-58149114612 10.2217/17460751.3.6.863
20. Ianus A., Holz G. G., Theise N. D., Hussain M. A., In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. Journal of Clinical Investigation 2003 111 6 843 850 2-s2.0-0037364517 10.1172/JCI200316502 (Pubitemid 37074959)
21. Ikehara S., Ohtsuki H., Good R. A., Prevention of type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. Proceedings of the National Academy of Sciences of the United States of America 1985 82 22 7743 7747 2-s2.0-0344338626 (Pubitemid 16204425)
22. Hasegawa Y., Ogihara T., Yamada T., Ishigaki Y., Imai J., Uno K., Gao J., Kaneko K., Ishihara H., Sasano H., Nakauchi H., Oka Y., Katagiri H., Bone marrow (BM) transplantation promotes β -cell regeneration after acute injury through BM cell mobilization. Endocrinology 2007 148 5 2006 2015 2-s2.0-34249796113 10.1210/en.2006-1351 (Pubitemid 46997048)
23. Yasumizu R., Sugiura K., Iwai H., Inaba M., Makino S., Ida T., Imura H., Hamashima Y., Good R. A., Ikehara S., Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue. Proceedings of the National Academy of Sciences of the United States of America 1987 84 18 6555 6557 2-s2.0-0023404463
24. Iwai H., Yasumizu R., Sugiura K., Inaba M., Kumazawa T., Good R. A., Ikehara S., Successful pancreatic allografts in combination with bone marrow transplantation in mice. Immunology 1987 62 3 457 462 2-s2.0-0023467379
25. Taira M., Inaba M., Takada K., Baba S., Fukui J., Ueda Y., Kwon A. H., Hisha H., Kamiyama Y., Ikehara S., Treatment of streptozotocin-induced diabetes mellitus in rats by transplantation of islet cells from two major histocompatibility complex disparate rats in combination with intra bone marrow injection of allogenic bone marrow cells. Transplantation 2005 79 6 680 687 2-s2.0-20144388320 10.1097/01.TP.0000155500.17348.94 (Pubitemid 40463174)
26. Cheng H., Zhang Y. C., Wolfe S., Combinatorial treatment of bone marrow stem cells and stromal cell-derived factor 1 improves glycemia and insulin production in diabetic mice. Molecular and Cellular Endocrinology 2011 345 88 96
27. Gabr M. M., Zakaria M. M., Refaie A. F., Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice. Cell Transplant. In press
28. Lee R. H., Seo M. J., Reger R. L., Spees J. L., Pulin A. A., Olson S. D., Prockop D. J., Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proceedings of the National Academy of Sciences of the United States of America 2006 103 46 17438 17443 2-s2.0-33751232671 10.1073/pnas.0608249103 (Pubitemid 44788987)
29. Urbán V. S., Kiss J., Kovács J., Gócza E., Vas V., Monostori E., Uher F., Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 2008 26 1 244 253 2-s2.0-38349062691 10.1634/stemcells.2007-0267
30. Fiorina P., Jurewicz M., Augello A., Vergani A., Dada S., La Rosa S., Selig M., Godwin J., Law K., Placidi C., Smith R. N., Capella C., Rodig S., Adra C. N., Atkinson M., Sayegh M. H., Abdi R., Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. Journal of Immunology 2009 183 2 993 1004 2-s2.0-70249122431 10.4049/jimmunol.0900803
31. Ezquer F., Ezquer M., Simon V., Conget P., The antidiabetic effect of MSCs is not impaired by insulin prophylaxis and is not improved by a second dose of cells. PLoS ONE 2011 6 1 2-s2.0-79551508886 10.1371/journal.pone.0016566 e16566
32. Milanesi A., Lee J. W., Li Z., beta-Cell regeneration mediated by human bone marrow mesenchymal stem cells. PLoS ONE 2012 7 e42177
33. Oikawa A., Siragusa M., Quaini F., Diabetes mellitus induces bone marrow microangiopathy. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 498 508
34. Loomans C. J. M., De Koning E. J. P., Staal F. J. T., Rookmaaker M. B., Verseyden C., De Boer H. C., Verhaar M. C., Braam B., Rabelink T. J., van Zonneveld A. J., Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004 53 1 195 199 2-s2.0-9144271032 10.2337/diabetes.53.1.195 (Pubitemid 38044715)
35. Tepper O. M., Galiano R. D., Capla J. M., Kalka C., Gagne P. J., Jacobowitz G. R., Levine J. P., Gurtner G. C., Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002 106 22 2781 2786 2-s2.0-0037180517 10.1161/01.CIR.0000039526.42991.93 (Pubitemid 35396976)
36. Mathews V., Hanson P. T., Ford E., Fujita J., Polonsky K. S., Graubert T. A., Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 2004 53 1 91 98 2-s2.0-0346099384 10.2337/diabetes.53.1.91 (Pubitemid 38044702)
37. Duffy G. P., Ahsan T., O'Brien T., Barry F., Nerem R. M., Bone marrow-derived mesenchymal stem cells promote angiogenic processes in a time- and dose-dependent manner in vitro. Tissue Engineering A 2009 15 9 2459 2470 2-s2.0-69249126590 10.1089/ten.tea.2008.0341
38. Tamama K., Sen C. K., Wells A., Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. Stem Cells and Development 2008 17 5 897 908 2-s2.0-58149145667 10.1089/scd.2007.0155
39. Yue W. M., Liu W., Bi Y. W., He X. P., Sun W. Y., Pang X. Y., Gu X. H., Wang X. P., Mesenchymal stem cells differentiate into an endothelial phenotype, reduce neointimal formation, and enhance endothelial function in a rat vein grafting model. Stem Cells and Development 2008 17 4 785 793 2-s2.0-51849110423 10.1089/scd.2008.0243
40. Gong Z., Niklason L. E., Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). The FASEB Journal 2008 22 6 1635 1648 2-s2.0-44949238649 10.1096/fj.07-087924 (Pubitemid 351811442)
41. Quevedo H. C., Hatzistergos K. E., Oskouei B. N., Feigenbaum G. S., Rodriguez J. E., Valdes D., Pattany P. M., Zambrano J. P., Hu Q., McNiece I., Heldman A. W., Hare J. M., Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proceedings of the National Academy of Sciences of the United States of America 2009 106 33 14022 14027 2-s2.0-69549138471 10.1073/pnas.0903201106
42. Wellen K. E., Hotamisligil G. S., Inflammation, stress, and diabetes. Journal of Clinical Investigation 2005 115 5 1111 1119 2-s2.0-18244370762 10.1172/JCI200525102 (Pubitemid 40629025)
43. Hotamisligil G. S., Inflammation and metabolic disorders. Nature 2006 444 7121 860 867 2-s2.0-33845866857 10.1038/nature05485 (Pubitemid 46024993)
44. Suganami T., Nishida J., Ogawa Y., A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 10 2062 2068 2-s2.0-26244448904 10.1161/01.ATV.0000183883.72263.13 (Pubitemid 41416301)
45. Fonseca V. A., Defining and characterizing the progression of type 2 diabetes. Diabetes Care 2009 32 supplement 2 S151 S156 2-s2.0-75549090118
46. Hanley S. C., Austin E., Assouline-Thomas B., Kapeluto J., Blaichman J., Moosavi M., Petropavlovskaia M., Rosenberg L., β -cell mass dynamics and islet cell plasticity in human type 2 diabetes. Endocrinology 2010 151 4 1462 1472 2-s2.0-77950290798 10.1210/en.2009-1277
47. Hathout E. H., Thomas W., El-Shahawy M., Nahab F., Mace J. W., Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics 2001 107 6 E102 2-s2.0-0035377557
48. Gilliam L. K., Brooks-Worrell B. M., Palmer J. P., Greenbaum C. J., Pihoker C., Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetes. Journal of Autoimmunity 2005 25 3 244 250 2-s2.0-27844507605 10.1016/j.jaut.2005.09.013 (Pubitemid 41656033)
49. Klingensmith G. J., Pyle L., Arslanian S., Copeland K. C., Cuttler L., Kaufman F., Laffel L., Marcovina S., Tollefsen S. E., Weinstock R. S., Linder B., The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care 2010 33 9 1970 1975 2-s2.0-78649953040 10.2337/dc10-0373
50. Than S., Ishida H., Inaba M., Fukuba Y., Seino Y., Adachi M., Imura H., Ikehara S., Bone marrow transplantation as a strategy for treatment of non-insulin- dependent diabetes mellitus in KK-Ay mice. Journal of Experimental Medicine 1992 176 4 1233 1238 2-s2.0-0026775984
51. Abraham N. G., Li M., Vanella L., Peterson S. J., Ikehara S., Asprinio D., Bone marrow stem cell transplant into intra-bone cavity prevents type 2 diabetes: role of heme oxygenase-adiponectin. Journal of Autoimmunity 2008 30 3 128 135 2-s2.0-39149103705 10.1016/j.jaut.2007.12.005
52. Boumaza I., Srinivasan S., Witt W. T., Feghali-Bostwick C., Dai Y., Garcia-Ocana A., Feili-Hariri M., Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia. Journal of Autoimmunity 2009 32 1 33 42 2-s2.0-59149098948 10.1016/j.jaut.2008.10.004
53. Estrada E. J., Valacchi F., Nicora E., Brieva S., Esteve C., Echevarria L., Froud T., Bernetti K., Cayetano S. M., Velazquez O., Alejandro R., Ricordi C., Combined treatment of intrapancreatic autologous bone marrow stem cells and hyperbaric oxygen in type 2 diabetes mellitus. Cell Transplantation 2008 17 12 1295 1304 2-s2.0-62549123720 10.3727/096368908787648119
54. Chua S. C. Jr., Chung W. K., Wu-Peng X. S., Zhang Y., Liu S. M., Tartaglia L., Leibel R. L., Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996 271 5251 994 996 2-s2.0-0030028959 (Pubitemid 26066874)
55. Fantuzzi G., Faggioni R., Leptin in the regulation of immunity, inflammation, and hematopoiesis. Journal of Leukocyte Biology 2000 68 4 437 446 2-s2.0-0033782028
56. Matarese G., Moschos S., Mantzoros C. S., Leptin in immunology. Journal of Immunology 2005 174 6 3137 3142 2-s2.0-14844363594 (Pubitemid 40354011)
57. Fernandes G., Handwerger B. S., Yunis E. J., Brown D. M., Immune response in the mutant diabetic C57BL/Ks-db+ mouse. Discrepancies between in vitro and in vivo immunological assays. Journal of Clinical Investigation 1978 61 2 243 250 2-s2.0-0017887735 (Pubitemid 8280393)
58. Kimura M., Tanaka S. I., Isoda F., Sekigawa K. I., Yamakawa T., Sekihara H., T lymphopenia in obese diabetic (db/db) mice is non-selective and thymus independent. Life Sciences 1998 62 14 1243 1250 2-s2.0-18744435491 10.1016/S0024-3205(98)00054-X (Pubitemid 28153507)
59. Li M., Abraham N. G., Vanella L., Zhang Y., Inaba M., Hosaka N., Hoshino S. I., Shi M., Ambrosini Y. M., Gershwin M. E., Ikehara S., Successful modulation of type 2 diabetes in db/db mice with intra-bone marrow-bone marrow transplantation plus concurrent thymic transplantation. Journal of Autoimmunity 2010 35 4 414 423 2-s2.0-77958124206 10.1016/j.jaut.2010.09.001
60. Li M., Vanella L., Zhang Y., Stem cell transplantation increases antioxidant effects in diabetic mice. International Journal of Biological Sciences 2012 8 1335 1344
61. Wang L., Zhao S., Mao H., Autologous bone marrow stem cell transplantation for the treatment of type 2 diabetes mellitus. Chinese Medical Journal 2011 124 3622 3628